nodes	percent_of_prediction	percent_of_DWPC	metapath
Atazanavir—CYP3A4—type 2 diabetes mellitus	0.185	1	CbGaD
Atazanavir—SLCO1B3—Pioglitazone—type 2 diabetes mellitus	0.0907	0.155	CbGbCtD
Atazanavir—SLCO1B3—Valsartan—type 2 diabetes mellitus	0.0739	0.126	CbGbCtD
Atazanavir—SLCO1B3—Losartan—type 2 diabetes mellitus	0.0425	0.0724	CbGbCtD
Atazanavir—ABCC1—Glyburide—type 2 diabetes mellitus	0.0321	0.0547	CbGbCtD
Atazanavir—ABCB1—Linagliptin—type 2 diabetes mellitus	0.0235	0.04	CbGbCtD
Atazanavir—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.0216	0.0368	CbGbCtD
Atazanavir—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.0209	0.0357	CbGbCtD
Atazanavir—CYP2C9—Glipizide—type 2 diabetes mellitus	0.0197	0.0336	CbGbCtD
Atazanavir—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.0183	0.0313	CbGbCtD
Atazanavir—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.0156	0.0266	CbGbCtD
Atazanavir—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.0156	0.0266	CbGbCtD
Atazanavir—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.0151	0.0258	CbGbCtD
Atazanavir—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.0144	0.0245	CbGbCtD
Atazanavir—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0141	0.024	CbGbCtD
Atazanavir—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.0139	0.0237	CbGbCtD
Atazanavir—CYP2C9—Valsartan—type 2 diabetes mellitus	0.0127	0.0217	CbGbCtD
Atazanavir—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0125	0.0214	CbGbCtD
Atazanavir—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.0118	0.0201	CbGbCtD
Atazanavir—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0115	0.0196	CbGbCtD
Atazanavir—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.0113	0.0193	CbGbCtD
Atazanavir—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.0104	0.0177	CbGbCtD
Atazanavir—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.01	0.0171	CbGbCtD
Atazanavir—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00906	0.0155	CbGbCtD
Atazanavir—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00798	0.0136	CbGbCtD
Atazanavir—ABCB1—Glyburide—type 2 diabetes mellitus	0.00774	0.0132	CbGbCtD
Atazanavir—CYP2C9—Losartan—type 2 diabetes mellitus	0.0073	0.0124	CbGbCtD
Atazanavir—ABCB1—Losartan—type 2 diabetes mellitus	0.00708	0.0121	CbGbCtD
Atazanavir—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00687	0.0117	CbGbCtD
Atazanavir—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00659	0.0112	CbGbCtD
Atazanavir—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00659	0.0112	CbGbCtD
Atazanavir—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00623	0.0106	CbGbCtD
Atazanavir—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00464	0.00791	CbGbCtD
Atazanavir—CYP3A4—Losartan—type 2 diabetes mellitus	0.00424	0.00724	CbGbCtD
Atazanavir—Saquinavir—CYP11A1—type 2 diabetes mellitus	0.000774	0.2	CrCbGaD
Atazanavir—Ritonavir—ABCC2—type 2 diabetes mellitus	0.000562	0.145	CrCbGaD
Atazanavir—Lopinavir—CYP1A2—type 2 diabetes mellitus	0.000446	0.115	CrCbGaD
Atazanavir—Saquinavir—ABCC2—type 2 diabetes mellitus	0.000426	0.11	CrCbGaD
Atazanavir—Ritonavir—CYP2E1—type 2 diabetes mellitus	0.000394	0.102	CrCbGaD
Atazanavir—Ritonavir—CYP1A2—type 2 diabetes mellitus	0.000375	0.0968	CrCbGaD
Atazanavir—Lopinavir—CYP3A4—type 2 diabetes mellitus	0.000295	0.0762	CrCbGaD
Atazanavir—Ritonavir—CYP3A4—type 2 diabetes mellitus	0.000248	0.0641	CrCbGaD
Atazanavir—Saquinavir—CYP3A4—type 2 diabetes mellitus	0.000188	0.0486	CrCbGaD
Atazanavir—Saquinavir—ALB—type 2 diabetes mellitus	0.000164	0.0424	CrCbGaD
Atazanavir—Dermatitis—Sitagliptin—type 2 diabetes mellitus	7.93e-05	0.000439	CcSEcCtD
Atazanavir—Erythema multiforme—Ramipril—type 2 diabetes mellitus	7.93e-05	0.000439	CcSEcCtD
Atazanavir—Headache—Glimepiride—type 2 diabetes mellitus	7.91e-05	0.000438	CcSEcCtD
Atazanavir—Ill-defined disorder—Losartan—type 2 diabetes mellitus	7.9e-05	0.000438	CcSEcCtD
Atazanavir—Cough—Irbesartan—type 2 diabetes mellitus	7.9e-05	0.000437	CcSEcCtD
Atazanavir—Headache—Sitagliptin—type 2 diabetes mellitus	7.89e-05	0.000437	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	7.83e-05	0.000434	CcSEcCtD
Atazanavir—Agitation—Losartan—type 2 diabetes mellitus	7.83e-05	0.000434	CcSEcCtD
Atazanavir—Oedema—Metformin—type 2 diabetes mellitus	7.83e-05	0.000434	CcSEcCtD
Atazanavir—Tinnitus—Ramipril—type 2 diabetes mellitus	7.82e-05	0.000433	CcSEcCtD
Atazanavir—Hypertension—Irbesartan—type 2 diabetes mellitus	7.81e-05	0.000433	CcSEcCtD
Atazanavir—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	7.8e-05	0.000432	CcSEcCtD
Atazanavir—Angioedema—Losartan—type 2 diabetes mellitus	7.78e-05	0.000431	CcSEcCtD
Atazanavir—Infection—Metformin—type 2 diabetes mellitus	7.77e-05	0.000431	CcSEcCtD
Atazanavir—Insomnia—Valsartan—type 2 diabetes mellitus	7.77e-05	0.000431	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	7.74e-05	0.000429	CcSEcCtD
Atazanavir—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	7.71e-05	0.000427	CcSEcCtD
Atazanavir—Myalgia—Irbesartan—type 2 diabetes mellitus	7.7e-05	0.000427	CcSEcCtD
Atazanavir—Chest pain—Irbesartan—type 2 diabetes mellitus	7.7e-05	0.000427	CcSEcCtD
Atazanavir—Arthralgia—Irbesartan—type 2 diabetes mellitus	7.7e-05	0.000427	CcSEcCtD
Atazanavir—Shock—Metformin—type 2 diabetes mellitus	7.7e-05	0.000427	CcSEcCtD
Atazanavir—Insomnia—Orlistat—type 2 diabetes mellitus	7.68e-05	0.000426	CcSEcCtD
Atazanavir—Malaise—Losartan—type 2 diabetes mellitus	7.68e-05	0.000425	CcSEcCtD
Atazanavir—Anxiety—Irbesartan—type 2 diabetes mellitus	7.68e-05	0.000425	CcSEcCtD
Atazanavir—Hypersensitivity—Glyburide—type 2 diabetes mellitus	7.67e-05	0.000425	CcSEcCtD
Atazanavir—Nervous system disorder—Metformin—type 2 diabetes mellitus	7.67e-05	0.000425	CcSEcCtD
Atazanavir—Dyspnoea—Valsartan—type 2 diabetes mellitus	7.66e-05	0.000424	CcSEcCtD
Atazanavir—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	7.65e-05	0.000424	CcSEcCtD
Atazanavir—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	7.65e-05	0.000424	CcSEcCtD
Atazanavir—Somnolence—Valsartan—type 2 diabetes mellitus	7.64e-05	0.000423	CcSEcCtD
Atazanavir—Syncope—Losartan—type 2 diabetes mellitus	7.64e-05	0.000423	CcSEcCtD
Atazanavir—Discomfort—Irbesartan—type 2 diabetes mellitus	7.61e-05	0.000422	CcSEcCtD
Atazanavir—Skin disorder—Metformin—type 2 diabetes mellitus	7.6e-05	0.000421	CcSEcCtD
Atazanavir—Immune system disorder—Ramipril—type 2 diabetes mellitus	7.58e-05	0.00042	CcSEcCtD
Atazanavir—Hyperhidrosis—Metformin—type 2 diabetes mellitus	7.56e-05	0.000419	CcSEcCtD
Atazanavir—Dyspepsia—Valsartan—type 2 diabetes mellitus	7.56e-05	0.000419	CcSEcCtD
Atazanavir—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	7.56e-05	0.000419	CcSEcCtD
Atazanavir—Dizziness—Bromocriptine—type 2 diabetes mellitus	7.53e-05	0.000417	CcSEcCtD
Atazanavir—Dry mouth—Irbesartan—type 2 diabetes mellitus	7.53e-05	0.000417	CcSEcCtD
Atazanavir—Palpitations—Losartan—type 2 diabetes mellitus	7.52e-05	0.000417	CcSEcCtD
Atazanavir—Nausea—Glimepiride—type 2 diabetes mellitus	7.5e-05	0.000416	CcSEcCtD
Atazanavir—Loss of consciousness—Losartan—type 2 diabetes mellitus	7.48e-05	0.000415	CcSEcCtD
Atazanavir—Nausea—Sitagliptin—type 2 diabetes mellitus	7.48e-05	0.000414	CcSEcCtD
Atazanavir—Dyspepsia—Orlistat—type 2 diabetes mellitus	7.47e-05	0.000414	CcSEcCtD
Atazanavir—Asthenia—Glyburide—type 2 diabetes mellitus	7.47e-05	0.000414	CcSEcCtD
Atazanavir—Decreased appetite—Valsartan—type 2 diabetes mellitus	7.47e-05	0.000414	CcSEcCtD
Atazanavir—Anorexia—Metformin—type 2 diabetes mellitus	7.46e-05	0.000413	CcSEcCtD
Atazanavir—Cough—Losartan—type 2 diabetes mellitus	7.43e-05	0.000412	CcSEcCtD
Atazanavir—Urticaria—Gliclazide—type 2 diabetes mellitus	7.43e-05	0.000412	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	7.42e-05	0.000411	CcSEcCtD
Atazanavir—Alopecia—Ramipril—type 2 diabetes mellitus	7.41e-05	0.000411	CcSEcCtD
Atazanavir—Fatigue—Valsartan—type 2 diabetes mellitus	7.41e-05	0.00041	CcSEcCtD
Atazanavir—Abdominal pain—Gliclazide—type 2 diabetes mellitus	7.39e-05	0.00041	CcSEcCtD
Atazanavir—Body temperature increased—Gliclazide—type 2 diabetes mellitus	7.39e-05	0.00041	CcSEcCtD
Atazanavir—Oedema—Irbesartan—type 2 diabetes mellitus	7.38e-05	0.000409	CcSEcCtD
Atazanavir—Decreased appetite—Orlistat—type 2 diabetes mellitus	7.38e-05	0.000409	CcSEcCtD
Atazanavir—Pruritus—Glyburide—type 2 diabetes mellitus	7.37e-05	0.000408	CcSEcCtD
Atazanavir—Mental disorder—Ramipril—type 2 diabetes mellitus	7.35e-05	0.000407	CcSEcCtD
Atazanavir—Constipation—Valsartan—type 2 diabetes mellitus	7.35e-05	0.000407	CcSEcCtD
Atazanavir—Infection—Irbesartan—type 2 diabetes mellitus	7.34e-05	0.000406	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	7.33e-05	0.000406	CcSEcCtD
Atazanavir—Fatigue—Orlistat—type 2 diabetes mellitus	7.32e-05	0.000406	CcSEcCtD
Atazanavir—Malnutrition—Ramipril—type 2 diabetes mellitus	7.3e-05	0.000405	CcSEcCtD
Atazanavir—Shock—Irbesartan—type 2 diabetes mellitus	7.27e-05	0.000403	CcSEcCtD
Atazanavir—Pain—Orlistat—type 2 diabetes mellitus	7.26e-05	0.000402	CcSEcCtD
Atazanavir—Chest pain—Losartan—type 2 diabetes mellitus	7.25e-05	0.000402	CcSEcCtD
Atazanavir—Arthralgia—Losartan—type 2 diabetes mellitus	7.25e-05	0.000402	CcSEcCtD
Atazanavir—Myalgia—Losartan—type 2 diabetes mellitus	7.25e-05	0.000402	CcSEcCtD
Atazanavir—Vomiting—Bromocriptine—type 2 diabetes mellitus	7.24e-05	0.000401	CcSEcCtD
Atazanavir—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	7.24e-05	0.000401	CcSEcCtD
Atazanavir—Anxiety—Losartan—type 2 diabetes mellitus	7.22e-05	0.0004	CcSEcCtD
Atazanavir—Rash—Bromocriptine—type 2 diabetes mellitus	7.18e-05	0.000398	CcSEcCtD
Atazanavir—Dermatitis—Bromocriptine—type 2 diabetes mellitus	7.18e-05	0.000398	CcSEcCtD
Atazanavir—Skin disorder—Irbesartan—type 2 diabetes mellitus	7.17e-05	0.000397	CcSEcCtD
Atazanavir—Tension—Ramipril—type 2 diabetes mellitus	7.16e-05	0.000397	CcSEcCtD
Atazanavir—Discomfort—Losartan—type 2 diabetes mellitus	7.16e-05	0.000397	CcSEcCtD
Atazanavir—Dysgeusia—Ramipril—type 2 diabetes mellitus	7.15e-05	0.000396	CcSEcCtD
Atazanavir—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	7.14e-05	0.000396	CcSEcCtD
Atazanavir—Headache—Bromocriptine—type 2 diabetes mellitus	7.14e-05	0.000395	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	7.13e-05	0.000395	CcSEcCtD
Atazanavir—Diarrhoea—Glyburide—type 2 diabetes mellitus	7.13e-05	0.000395	CcSEcCtD
Atazanavir—Nervousness—Ramipril—type 2 diabetes mellitus	7.09e-05	0.000393	CcSEcCtD
Atazanavir—Dry mouth—Losartan—type 2 diabetes mellitus	7.09e-05	0.000393	CcSEcCtD
Atazanavir—Anorexia—Irbesartan—type 2 diabetes mellitus	7.04e-05	0.00039	CcSEcCtD
Atazanavir—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	7.03e-05	0.000389	CcSEcCtD
Atazanavir—Confusional state—Losartan—type 2 diabetes mellitus	7.01e-05	0.000388	CcSEcCtD
Atazanavir—Feeling abnormal—Orlistat—type 2 diabetes mellitus	7e-05	0.000388	CcSEcCtD
Atazanavir—Dyspnoea—Metformin—type 2 diabetes mellitus	6.98e-05	0.000387	CcSEcCtD
Atazanavir—Somnolence—Metformin—type 2 diabetes mellitus	6.96e-05	0.000385	CcSEcCtD
Atazanavir—Oedema—Losartan—type 2 diabetes mellitus	6.95e-05	0.000385	CcSEcCtD
Atazanavir—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	6.94e-05	0.000385	CcSEcCtD
Atazanavir—Infection—Losartan—type 2 diabetes mellitus	6.9e-05	0.000383	CcSEcCtD
Atazanavir—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	6.89e-05	0.000382	CcSEcCtD
Atazanavir—Dyspepsia—Metformin—type 2 diabetes mellitus	6.89e-05	0.000382	CcSEcCtD
Atazanavir—Shock—Losartan—type 2 diabetes mellitus	6.84e-05	0.000379	CcSEcCtD
Atazanavir—Urticaria—Valsartan—type 2 diabetes mellitus	6.83e-05	0.000378	CcSEcCtD
Atazanavir—Nervous system disorder—Losartan—type 2 diabetes mellitus	6.82e-05	0.000378	CcSEcCtD
Atazanavir—Decreased appetite—Metformin—type 2 diabetes mellitus	6.8e-05	0.000377	CcSEcCtD
Atazanavir—Abdominal pain—Valsartan—type 2 diabetes mellitus	6.79e-05	0.000376	CcSEcCtD
Atazanavir—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	6.77e-05	0.000375	CcSEcCtD
Atazanavir—Nausea—Bromocriptine—type 2 diabetes mellitus	6.77e-05	0.000375	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	6.76e-05	0.000374	CcSEcCtD
Atazanavir—Fatigue—Metformin—type 2 diabetes mellitus	6.75e-05	0.000374	CcSEcCtD
Atazanavir—Urticaria—Orlistat—type 2 diabetes mellitus	6.75e-05	0.000374	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	6.73e-05	0.000373	CcSEcCtD
Atazanavir—Hyperhidrosis—Losartan—type 2 diabetes mellitus	6.72e-05	0.000372	CcSEcCtD
Atazanavir—Abdominal pain—Orlistat—type 2 diabetes mellitus	6.71e-05	0.000372	CcSEcCtD
Atazanavir—Body temperature increased—Orlistat—type 2 diabetes mellitus	6.71e-05	0.000372	CcSEcCtD
Atazanavir—Asthenia—Gliclazide—type 2 diabetes mellitus	6.71e-05	0.000372	CcSEcCtD
Atazanavir—Agitation—Ramipril—type 2 diabetes mellitus	6.71e-05	0.000372	CcSEcCtD
Atazanavir—Constipation—Metformin—type 2 diabetes mellitus	6.69e-05	0.000371	CcSEcCtD
Atazanavir—Angioedema—Ramipril—type 2 diabetes mellitus	6.67e-05	0.00037	CcSEcCtD
Atazanavir—Anorexia—Losartan—type 2 diabetes mellitus	6.62e-05	0.000367	CcSEcCtD
Atazanavir—Vomiting—Glyburide—type 2 diabetes mellitus	6.62e-05	0.000367	CcSEcCtD
Atazanavir—Pruritus—Gliclazide—type 2 diabetes mellitus	6.62e-05	0.000367	CcSEcCtD
Atazanavir—Malaise—Ramipril—type 2 diabetes mellitus	6.58e-05	0.000365	CcSEcCtD
Atazanavir—Dyspnoea—Irbesartan—type 2 diabetes mellitus	6.58e-05	0.000365	CcSEcCtD
Atazanavir—Rash—Glyburide—type 2 diabetes mellitus	6.57e-05	0.000364	CcSEcCtD
Atazanavir—Somnolence—Irbesartan—type 2 diabetes mellitus	6.56e-05	0.000364	CcSEcCtD
Atazanavir—Dermatitis—Glyburide—type 2 diabetes mellitus	6.56e-05	0.000364	CcSEcCtD
Atazanavir—Syncope—Ramipril—type 2 diabetes mellitus	6.55e-05	0.000363	CcSEcCtD
Atazanavir—Headache—Glyburide—type 2 diabetes mellitus	6.53e-05	0.000362	CcSEcCtD
Atazanavir—Dyspepsia—Irbesartan—type 2 diabetes mellitus	6.5e-05	0.00036	CcSEcCtD
Atazanavir—Palpitations—Ramipril—type 2 diabetes mellitus	6.45e-05	0.000358	CcSEcCtD
Atazanavir—Feeling abnormal—Metformin—type 2 diabetes mellitus	6.45e-05	0.000357	CcSEcCtD
Atazanavir—Decreased appetite—Irbesartan—type 2 diabetes mellitus	6.42e-05	0.000356	CcSEcCtD
Atazanavir—Loss of consciousness—Ramipril—type 2 diabetes mellitus	6.42e-05	0.000356	CcSEcCtD
Atazanavir—Diarrhoea—Gliclazide—type 2 diabetes mellitus	6.4e-05	0.000355	CcSEcCtD
Atazanavir—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	6.4e-05	0.000355	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	6.38e-05	0.000353	CcSEcCtD
Atazanavir—Cough—Ramipril—type 2 diabetes mellitus	6.37e-05	0.000353	CcSEcCtD
Atazanavir—Fatigue—Irbesartan—type 2 diabetes mellitus	6.37e-05	0.000353	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	6.33e-05	0.000351	CcSEcCtD
Atazanavir—Hypersensitivity—Valsartan—type 2 diabetes mellitus	6.33e-05	0.000351	CcSEcCtD
Atazanavir—Convulsion—Ramipril—type 2 diabetes mellitus	6.33e-05	0.000351	CcSEcCtD
Atazanavir—Constipation—Irbesartan—type 2 diabetes mellitus	6.31e-05	0.00035	CcSEcCtD
Atazanavir—Pain—Irbesartan—type 2 diabetes mellitus	6.31e-05	0.00035	CcSEcCtD
Atazanavir—Insomnia—Losartan—type 2 diabetes mellitus	6.29e-05	0.000348	CcSEcCtD
Atazanavir—Hypersensitivity—Orlistat—type 2 diabetes mellitus	6.26e-05	0.000347	CcSEcCtD
Atazanavir—Urticaria—Metformin—type 2 diabetes mellitus	6.22e-05	0.000344	CcSEcCtD
Atazanavir—Arthralgia—Ramipril—type 2 diabetes mellitus	6.22e-05	0.000344	CcSEcCtD
Atazanavir—Chest pain—Ramipril—type 2 diabetes mellitus	6.22e-05	0.000344	CcSEcCtD
Atazanavir—Myalgia—Ramipril—type 2 diabetes mellitus	6.22e-05	0.000344	CcSEcCtD
Atazanavir—Dyspnoea—Losartan—type 2 diabetes mellitus	6.2e-05	0.000343	CcSEcCtD
Atazanavir—Anxiety—Ramipril—type 2 diabetes mellitus	6.19e-05	0.000343	CcSEcCtD
Atazanavir—Nausea—Glyburide—type 2 diabetes mellitus	6.19e-05	0.000343	CcSEcCtD
Atazanavir—Abdominal pain—Metformin—type 2 diabetes mellitus	6.19e-05	0.000343	CcSEcCtD
Atazanavir—Dizziness—Gliclazide—type 2 diabetes mellitus	6.18e-05	0.000343	CcSEcCtD
Atazanavir—Somnolence—Losartan—type 2 diabetes mellitus	6.18e-05	0.000342	CcSEcCtD
Atazanavir—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	6.17e-05	0.000342	CcSEcCtD
Atazanavir—Asthenia—Valsartan—type 2 diabetes mellitus	6.17e-05	0.000342	CcSEcCtD
Atazanavir—Discomfort—Ramipril—type 2 diabetes mellitus	6.14e-05	0.00034	CcSEcCtD
Atazanavir—Dyspepsia—Losartan—type 2 diabetes mellitus	6.12e-05	0.000339	CcSEcCtD
Atazanavir—Asthenia—Orlistat—type 2 diabetes mellitus	6.09e-05	0.000338	CcSEcCtD
Atazanavir—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	6.09e-05	0.000337	CcSEcCtD
Atazanavir—Pruritus—Valsartan—type 2 diabetes mellitus	6.08e-05	0.000337	CcSEcCtD
Atazanavir—Dry mouth—Ramipril—type 2 diabetes mellitus	6.08e-05	0.000337	CcSEcCtD
Atazanavir—Decreased appetite—Losartan—type 2 diabetes mellitus	6.04e-05	0.000335	CcSEcCtD
Atazanavir—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	6.04e-05	0.000335	CcSEcCtD
Atazanavir—Confusional state—Ramipril—type 2 diabetes mellitus	6.01e-05	0.000333	CcSEcCtD
Atazanavir—Pruritus—Orlistat—type 2 diabetes mellitus	6.01e-05	0.000333	CcSEcCtD
Atazanavir—Fatigue—Losartan—type 2 diabetes mellitus	5.99e-05	0.000332	CcSEcCtD
Atazanavir—Oedema—Ramipril—type 2 diabetes mellitus	5.96e-05	0.00033	CcSEcCtD
Atazanavir—Vomiting—Gliclazide—type 2 diabetes mellitus	5.95e-05	0.000329	CcSEcCtD
Atazanavir—Constipation—Losartan—type 2 diabetes mellitus	5.94e-05	0.000329	CcSEcCtD
Atazanavir—Pain—Losartan—type 2 diabetes mellitus	5.94e-05	0.000329	CcSEcCtD
Atazanavir—Rash—Gliclazide—type 2 diabetes mellitus	5.9e-05	0.000327	CcSEcCtD
Atazanavir—Dermatitis—Gliclazide—type 2 diabetes mellitus	5.89e-05	0.000326	CcSEcCtD
Atazanavir—Diarrhoea—Valsartan—type 2 diabetes mellitus	5.88e-05	0.000326	CcSEcCtD
Atazanavir—Urticaria—Irbesartan—type 2 diabetes mellitus	5.87e-05	0.000325	CcSEcCtD
Atazanavir—Shock—Ramipril—type 2 diabetes mellitus	5.86e-05	0.000325	CcSEcCtD
Atazanavir—Headache—Gliclazide—type 2 diabetes mellitus	5.86e-05	0.000325	CcSEcCtD
Atazanavir—Nervous system disorder—Ramipril—type 2 diabetes mellitus	5.84e-05	0.000324	CcSEcCtD
Atazanavir—Abdominal pain—Irbesartan—type 2 diabetes mellitus	5.84e-05	0.000323	CcSEcCtD
Atazanavir—Body temperature increased—Irbesartan—type 2 diabetes mellitus	5.84e-05	0.000323	CcSEcCtD
Atazanavir—Diarrhoea—Orlistat—type 2 diabetes mellitus	5.81e-05	0.000322	CcSEcCtD
Atazanavir—Skin disorder—Ramipril—type 2 diabetes mellitus	5.79e-05	0.000321	CcSEcCtD
Atazanavir—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	5.76e-05	0.000319	CcSEcCtD
Atazanavir—Feeling abnormal—Losartan—type 2 diabetes mellitus	5.73e-05	0.000317	CcSEcCtD
Atazanavir—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	5.68e-05	0.000315	CcSEcCtD
Atazanavir—Dizziness—Valsartan—type 2 diabetes mellitus	5.68e-05	0.000315	CcSEcCtD
Atazanavir—Anorexia—Ramipril—type 2 diabetes mellitus	5.68e-05	0.000315	CcSEcCtD
Atazanavir—Dizziness—Orlistat—type 2 diabetes mellitus	5.61e-05	0.000311	CcSEcCtD
Atazanavir—Asthenia—Metformin—type 2 diabetes mellitus	5.61e-05	0.000311	CcSEcCtD
Atazanavir—Nausea—Gliclazide—type 2 diabetes mellitus	5.56e-05	0.000308	CcSEcCtD
Atazanavir—Pruritus—Metformin—type 2 diabetes mellitus	5.54e-05	0.000307	CcSEcCtD
Atazanavir—Urticaria—Losartan—type 2 diabetes mellitus	5.52e-05	0.000306	CcSEcCtD
Atazanavir—Body temperature increased—Losartan—type 2 diabetes mellitus	5.49e-05	0.000304	CcSEcCtD
Atazanavir—Abdominal pain—Losartan—type 2 diabetes mellitus	5.49e-05	0.000304	CcSEcCtD
Atazanavir—Vomiting—Valsartan—type 2 diabetes mellitus	5.46e-05	0.000303	CcSEcCtD
Atazanavir—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	5.44e-05	0.000301	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	5.43e-05	0.000301	CcSEcCtD
Atazanavir—Rash—Valsartan—type 2 diabetes mellitus	5.42e-05	0.0003	CcSEcCtD
Atazanavir—Dermatitis—Valsartan—type 2 diabetes mellitus	5.41e-05	0.0003	CcSEcCtD
Atazanavir—Vomiting—Orlistat—type 2 diabetes mellitus	5.4e-05	0.000299	CcSEcCtD
Atazanavir—Insomnia—Ramipril—type 2 diabetes mellitus	5.39e-05	0.000299	CcSEcCtD
Atazanavir—Headache—Valsartan—type 2 diabetes mellitus	5.38e-05	0.000298	CcSEcCtD
Atazanavir—Diarrhoea—Metformin—type 2 diabetes mellitus	5.35e-05	0.000297	CcSEcCtD
Atazanavir—Rash—Orlistat—type 2 diabetes mellitus	5.35e-05	0.000297	CcSEcCtD
Atazanavir—Dermatitis—Orlistat—type 2 diabetes mellitus	5.35e-05	0.000296	CcSEcCtD
Atazanavir—Headache—Orlistat—type 2 diabetes mellitus	5.32e-05	0.000295	CcSEcCtD
Atazanavir—Dyspnoea—Ramipril—type 2 diabetes mellitus	5.31e-05	0.000294	CcSEcCtD
Atazanavir—Asthenia—Irbesartan—type 2 diabetes mellitus	5.3e-05	0.000294	CcSEcCtD
Atazanavir—Somnolence—Ramipril—type 2 diabetes mellitus	5.3e-05	0.000294	CcSEcCtD
Atazanavir—Dyspepsia—Ramipril—type 2 diabetes mellitus	5.25e-05	0.000291	CcSEcCtD
Atazanavir—Pruritus—Irbesartan—type 2 diabetes mellitus	5.22e-05	0.000289	CcSEcCtD
Atazanavir—Decreased appetite—Ramipril—type 2 diabetes mellitus	5.18e-05	0.000287	CcSEcCtD
Atazanavir—Dizziness—Metformin—type 2 diabetes mellitus	5.17e-05	0.000287	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	5.14e-05	0.000285	CcSEcCtD
Atazanavir—Fatigue—Ramipril—type 2 diabetes mellitus	5.14e-05	0.000285	CcSEcCtD
Atazanavir—Hypersensitivity—Losartan—type 2 diabetes mellitus	5.12e-05	0.000284	CcSEcCtD
Atazanavir—Nausea—Valsartan—type 2 diabetes mellitus	5.1e-05	0.000283	CcSEcCtD
Atazanavir—Constipation—Ramipril—type 2 diabetes mellitus	5.1e-05	0.000282	CcSEcCtD
Atazanavir—Diarrhoea—Irbesartan—type 2 diabetes mellitus	5.05e-05	0.00028	CcSEcCtD
Atazanavir—Nausea—Orlistat—type 2 diabetes mellitus	5.04e-05	0.000279	CcSEcCtD
Atazanavir—Asthenia—Losartan—type 2 diabetes mellitus	4.99e-05	0.000276	CcSEcCtD
Atazanavir—Vomiting—Metformin—type 2 diabetes mellitus	4.98e-05	0.000276	CcSEcCtD
Atazanavir—Rash—Metformin—type 2 diabetes mellitus	4.93e-05	0.000273	CcSEcCtD
Atazanavir—Dermatitis—Metformin—type 2 diabetes mellitus	4.93e-05	0.000273	CcSEcCtD
Atazanavir—Pruritus—Losartan—type 2 diabetes mellitus	4.92e-05	0.000272	CcSEcCtD
Atazanavir—Feeling abnormal—Ramipril—type 2 diabetes mellitus	4.91e-05	0.000272	CcSEcCtD
Atazanavir—Headache—Metformin—type 2 diabetes mellitus	4.9e-05	0.000272	CcSEcCtD
Atazanavir—Dizziness—Irbesartan—type 2 diabetes mellitus	4.88e-05	0.000271	CcSEcCtD
Atazanavir—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	4.87e-05	0.00027	CcSEcCtD
Atazanavir—Diarrhoea—Losartan—type 2 diabetes mellitus	4.75e-05	0.000263	CcSEcCtD
Atazanavir—Urticaria—Ramipril—type 2 diabetes mellitus	4.73e-05	0.000262	CcSEcCtD
Atazanavir—Body temperature increased—Ramipril—type 2 diabetes mellitus	4.71e-05	0.000261	CcSEcCtD
Atazanavir—Abdominal pain—Ramipril—type 2 diabetes mellitus	4.71e-05	0.000261	CcSEcCtD
Atazanavir—Vomiting—Irbesartan—type 2 diabetes mellitus	4.7e-05	0.00026	CcSEcCtD
Atazanavir—Rash—Irbesartan—type 2 diabetes mellitus	4.66e-05	0.000258	CcSEcCtD
Atazanavir—Dermatitis—Irbesartan—type 2 diabetes mellitus	4.65e-05	0.000258	CcSEcCtD
Atazanavir—Nausea—Metformin—type 2 diabetes mellitus	4.65e-05	0.000258	CcSEcCtD
Atazanavir—Headache—Irbesartan—type 2 diabetes mellitus	4.63e-05	0.000256	CcSEcCtD
Atazanavir—Dizziness—Losartan—type 2 diabetes mellitus	4.6e-05	0.000255	CcSEcCtD
Atazanavir—Vomiting—Losartan—type 2 diabetes mellitus	4.42e-05	0.000245	CcSEcCtD
Atazanavir—Hypersensitivity—Ramipril—type 2 diabetes mellitus	4.39e-05	0.000243	CcSEcCtD
Atazanavir—Nausea—Irbesartan—type 2 diabetes mellitus	4.39e-05	0.000243	CcSEcCtD
Atazanavir—Rash—Losartan—type 2 diabetes mellitus	4.38e-05	0.000243	CcSEcCtD
Atazanavir—Dermatitis—Losartan—type 2 diabetes mellitus	4.38e-05	0.000243	CcSEcCtD
Atazanavir—Headache—Losartan—type 2 diabetes mellitus	4.35e-05	0.000241	CcSEcCtD
Atazanavir—Asthenia—Ramipril—type 2 diabetes mellitus	4.28e-05	0.000237	CcSEcCtD
Atazanavir—Pruritus—Ramipril—type 2 diabetes mellitus	4.22e-05	0.000234	CcSEcCtD
Atazanavir—Nausea—Losartan—type 2 diabetes mellitus	4.13e-05	0.000229	CcSEcCtD
Atazanavir—Diarrhoea—Ramipril—type 2 diabetes mellitus	4.08e-05	0.000226	CcSEcCtD
Atazanavir—Dizziness—Ramipril—type 2 diabetes mellitus	3.94e-05	0.000218	CcSEcCtD
Atazanavir—Vomiting—Ramipril—type 2 diabetes mellitus	3.79e-05	0.00021	CcSEcCtD
Atazanavir—Rash—Ramipril—type 2 diabetes mellitus	3.76e-05	0.000208	CcSEcCtD
Atazanavir—Dermatitis—Ramipril—type 2 diabetes mellitus	3.75e-05	0.000208	CcSEcCtD
Atazanavir—Headache—Ramipril—type 2 diabetes mellitus	3.73e-05	0.000207	CcSEcCtD
Atazanavir—Nausea—Ramipril—type 2 diabetes mellitus	3.54e-05	0.000196	CcSEcCtD
Atazanavir—ABCC1—Disease—MTHFR—type 2 diabetes mellitus	1.12e-05	0.000254	CbGpPWpGaD
Atazanavir—ABCB1—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	1.1e-05	0.000251	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—type 2 diabetes mellitus	1.1e-05	0.000251	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—AK1—type 2 diabetes mellitus	1.09e-05	0.000249	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—APOB—type 2 diabetes mellitus	1.09e-05	0.000247	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	1.08e-05	0.000247	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—type 2 diabetes mellitus	1.08e-05	0.000246	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—PPARG—type 2 diabetes mellitus	1.07e-05	0.000244	CbGpPWpGaD
Atazanavir—ABCC1—Disease—HIF1A—type 2 diabetes mellitus	1.06e-05	0.000242	CbGpPWpGaD
Atazanavir—ABCC1—Disease—IRS2—type 2 diabetes mellitus	1.06e-05	0.000242	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—GSTM1—type 2 diabetes mellitus	1.06e-05	0.000241	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—HK1—type 2 diabetes mellitus	1.05e-05	0.00024	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PCK1—type 2 diabetes mellitus	1.05e-05	0.00024	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—INS—type 2 diabetes mellitus	1.05e-05	0.000239	CbGpPWpGaD
Atazanavir—ABCC1—Disease—CALM1—type 2 diabetes mellitus	1.04e-05	0.000237	CbGpPWpGaD
Atazanavir—ABCC1—Disease—APOE—type 2 diabetes mellitus	1.04e-05	0.000237	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—LPL—type 2 diabetes mellitus	1.04e-05	0.000236	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	1.04e-05	0.000236	CbGpPWpGaD
Atazanavir—ABCB1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	1.03e-05	0.000235	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	1.03e-05	0.000234	CbGpPWpGaD
Atazanavir—ABCC1—Disease—APOA1—type 2 diabetes mellitus	1.03e-05	0.000234	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—KCNJ11—type 2 diabetes mellitus	1.02e-05	0.000232	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—GCKR—type 2 diabetes mellitus	1.02e-05	0.000232	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—LPA—type 2 diabetes mellitus	1.02e-05	0.000232	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—HSD3B2—type 2 diabetes mellitus	1.02e-05	0.000232	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—ADCY5—type 2 diabetes mellitus	1.02e-05	0.000231	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—GPX1—type 2 diabetes mellitus	1.01e-05	0.000231	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	1.01e-05	0.00023	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	1.01e-05	0.00023	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	1.01e-05	0.00023	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—CD36—type 2 diabetes mellitus	9.86e-06	0.000225	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—HK1—type 2 diabetes mellitus	9.85e-06	0.000224	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	9.84e-06	0.000224	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—ALDOB—type 2 diabetes mellitus	9.76e-06	0.000222	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	9.73e-06	0.000222	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	9.73e-06	0.000222	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	9.73e-06	0.000222	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	9.73e-06	0.000222	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	9.73e-06	0.000222	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—PPP2CA—type 2 diabetes mellitus	9.73e-06	0.000222	CbGpPWpGaD
Atazanavir—ABCC1—Disease—NOS2—type 2 diabetes mellitus	9.67e-06	0.00022	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—ALB—type 2 diabetes mellitus	9.63e-06	0.000219	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—GCKR—type 2 diabetes mellitus	9.51e-06	0.000217	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—KCNJ11—type 2 diabetes mellitus	9.51e-06	0.000217	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—HSD3B2—type 2 diabetes mellitus	9.51e-06	0.000217	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—LPA—type 2 diabetes mellitus	9.51e-06	0.000217	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	9.43e-06	0.000215	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—MTHFR—type 2 diabetes mellitus	9.34e-06	0.000213	CbGpPWpGaD
Atazanavir—ABCB1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	9.31e-06	0.000212	CbGpPWpGaD
Atazanavir—ABCC1—Disease—IRS1—type 2 diabetes mellitus	9.26e-06	0.000211	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—PIK3R1—type 2 diabetes mellitus	9.21e-06	0.00021	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—NOS3—type 2 diabetes mellitus	9.21e-06	0.00021	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—PPARA—type 2 diabetes mellitus	9.16e-06	0.000209	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	9.14e-06	0.000208	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—ALDOB—type 2 diabetes mellitus	9.12e-06	0.000208	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—GLP1R—type 2 diabetes mellitus	9.07e-06	0.000207	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	8.9e-06	0.000203	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	8.9e-06	0.000203	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—AGT—type 2 diabetes mellitus	8.87e-06	0.000202	CbGpPWpGaD
Atazanavir—ABCC1—Disease—INS—type 2 diabetes mellitus	8.87e-06	0.000202	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	8.86e-06	0.000202	CbGpPWpGaD
Atazanavir—ABCB1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	8.73e-06	0.000199	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—CALM1—type 2 diabetes mellitus	8.73e-06	0.000199	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—APOE—type 2 diabetes mellitus	8.69e-06	0.000198	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	8.68e-06	0.000198	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	8.67e-06	0.000198	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—APOA1—type 2 diabetes mellitus	8.6e-06	0.000196	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	8.58e-06	0.000195	CbGpPWpGaD
Atazanavir—ABCC1—Disease—AKT2—type 2 diabetes mellitus	8.57e-06	0.000195	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—GLP1R—type 2 diabetes mellitus	8.48e-06	0.000193	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—SLC2A2—type 2 diabetes mellitus	8.47e-06	0.000193	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—PTGS2—type 2 diabetes mellitus	8.43e-06	0.000192	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—MTR—type 2 diabetes mellitus	8.3e-06	0.000189	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CPT1A—type 2 diabetes mellitus	8.3e-06	0.000189	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	8.28e-06	0.000189	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	8.28e-06	0.000189	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	8.28e-06	0.000189	CbGpPWpGaD
Atazanavir—ABCC1—Disease—SERPINE1—type 2 diabetes mellitus	8.15e-06	0.000186	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—NAMPT—type 2 diabetes mellitus	8.14e-06	0.000185	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—LIPC—type 2 diabetes mellitus	8.09e-06	0.000184	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—HBA1—type 2 diabetes mellitus	8.09e-06	0.000184	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—GCK—type 2 diabetes mellitus	8.09e-06	0.000184	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CYP11A1—type 2 diabetes mellitus	8.04e-06	0.000183	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	7.93e-06	0.000181	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	7.93e-06	0.000181	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—SLC2A2—type 2 diabetes mellitus	7.91e-06	0.00018	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—SLC9A1—type 2 diabetes mellitus	7.89e-06	0.00018	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CETP—type 2 diabetes mellitus	7.8e-06	0.000178	CbGpPWpGaD
Atazanavir—ABCC1—Disease—PIK3R1—type 2 diabetes mellitus	7.78e-06	0.000177	CbGpPWpGaD
Atazanavir—ABCC1—Disease—NOS3—type 2 diabetes mellitus	7.78e-06	0.000177	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—MTR—type 2 diabetes mellitus	7.75e-06	0.000177	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CPT1A—type 2 diabetes mellitus	7.75e-06	0.000177	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	7.66e-06	0.000175	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	7.64e-06	0.000174	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	7.64e-06	0.000174	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—NAMPT—type 2 diabetes mellitus	7.6e-06	0.000173	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—PPARG—type 2 diabetes mellitus	7.57e-06	0.000173	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	7.56e-06	0.000172	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—LIPC—type 2 diabetes mellitus	7.55e-06	0.000172	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—HBA1—type 2 diabetes mellitus	7.55e-06	0.000172	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—GCK—type 2 diabetes mellitus	7.55e-06	0.000172	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CYP11A1—type 2 diabetes mellitus	7.51e-06	0.000171	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	7.5e-06	0.000171	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—INS—type 2 diabetes mellitus	7.43e-06	0.000169	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	7.38e-06	0.000168	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	7.38e-06	0.000168	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	7.38e-06	0.000168	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—SLC9A1—type 2 diabetes mellitus	7.37e-06	0.000168	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CETP—type 2 diabetes mellitus	7.29e-06	0.000166	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PSMD6—type 2 diabetes mellitus	7.25e-06	0.000165	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—SNAP25—type 2 diabetes mellitus	7.25e-06	0.000165	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—SREBF1—type 2 diabetes mellitus	7.25e-06	0.000165	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CTGF—type 2 diabetes mellitus	7.12e-06	0.000162	CbGpPWpGaD
Atazanavir—ABCC1—Disease—PTGS2—type 2 diabetes mellitus	7.11e-06	0.000162	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—HMGCR—type 2 diabetes mellitus	7.06e-06	0.000161	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	6.93e-06	0.000158	CbGpPWpGaD
Atazanavir—ABCB1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	6.92e-06	0.000158	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—ADRA2A—type 2 diabetes mellitus	6.9e-06	0.000157	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—ALB—type 2 diabetes mellitus	6.81e-06	0.000155	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	6.8e-06	0.000155	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—SREBF1—type 2 diabetes mellitus	6.78e-06	0.000154	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PSMD6—type 2 diabetes mellitus	6.78e-06	0.000154	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—SNAP25—type 2 diabetes mellitus	6.78e-06	0.000154	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CTGF—type 2 diabetes mellitus	6.65e-06	0.000152	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CYP2E1—type 2 diabetes mellitus	6.63e-06	0.000151	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	6.59e-06	0.00015	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—SLC2A1—type 2 diabetes mellitus	6.56e-06	0.000149	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CYP1A2—type 2 diabetes mellitus	6.56e-06	0.000149	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—NOS3—type 2 diabetes mellitus	6.51e-06	0.000148	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—PIK3R1—type 2 diabetes mellitus	6.51e-06	0.000148	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	6.5e-06	0.000148	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	6.49e-06	0.000148	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	6.45e-06	0.000147	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CYP3A4—type 2 diabetes mellitus	6.4e-06	0.000146	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—GCG—type 2 diabetes mellitus	6.29e-06	0.000143	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—SLC2A4—type 2 diabetes mellitus	6.29e-06	0.000143	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	6.27e-06	0.000143	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	6.27e-06	0.000143	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	6.27e-06	0.000143	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	6.27e-06	0.000143	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	6.2e-06	0.000141	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	6.13e-06	0.00014	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	6.13e-06	0.00014	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	6.01e-06	0.000137	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	5.98e-06	0.000136	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—PTGS2—type 2 diabetes mellitus	5.96e-06	0.000136	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	5.95e-06	0.000135	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	5.88e-06	0.000134	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	5.88e-06	0.000134	CbGpPWpGaD
Atazanavir—ABCC1—Disease—SRC—type 2 diabetes mellitus	5.75e-06	0.000131	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	5.59e-06	0.000127	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.42e-06	0.000123	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	5.42e-06	0.000123	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	5.4e-06	0.000123	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	5.32e-06	0.000121	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	5.22e-06	0.000119	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	5.17e-06	0.000118	CbGpPWpGaD
Atazanavir—ABCC1—Disease—TGFB1—type 2 diabetes mellitus	5.14e-06	0.000117	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	5.11e-06	0.000116	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	5.11e-06	0.000116	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.06e-06	0.000115	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	5.06e-06	0.000115	CbGpPWpGaD
Atazanavir—ABCC1—Disease—EGFR—type 2 diabetes mellitus	5.04e-06	0.000115	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	5.04e-06	0.000115	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	5.03e-06	0.000115	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	5.01e-06	0.000114	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	4.98e-06	0.000114	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	4.98e-06	0.000114	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	4.98e-06	0.000114	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	4.97e-06	0.000113	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	4.95e-06	0.000113	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	4.93e-06	0.000112	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	4.86e-06	0.000111	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	4.83e-06	0.00011	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	4.83e-06	0.00011	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	4.81e-06	0.00011	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	4.81e-06	0.00011	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	4.7e-06	0.000107	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	4.69e-06	0.000107	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	4.63e-06	0.000105	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	4.61e-06	0.000105	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	4.51e-06	0.000103	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	4.5e-06	0.000102	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	4.47e-06	0.000102	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	4.47e-06	0.000102	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	4.47e-06	0.000102	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	4.44e-06	0.000101	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	4.39e-06	9.99e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	4.38e-06	9.98e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	4.36e-06	9.93e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	4.35e-06	9.9e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	4.33e-06	9.85e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	4.25e-06	9.69e-05	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—AKT1—type 2 diabetes mellitus	4.24e-06	9.65e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	4.22e-06	9.62e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	4.15e-06	9.46e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	4.15e-06	9.46e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	4.14e-06	9.42e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	4.09e-06	9.32e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	4.09e-06	9.31e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	4.07e-06	9.28e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	4.04e-06	9.21e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	4.04e-06	9.21e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	3.94e-06	8.99e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	3.88e-06	8.83e-05	CbGpPWpGaD
Atazanavir—ABCC1—Disease—IL6—type 2 diabetes mellitus	3.88e-06	8.83e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	3.87e-06	8.83e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	3.87e-06	8.83e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	3.86e-06	8.8e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	3.82e-06	8.7e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	3.6e-06	8.21e-05	CbGpPWpGaD
Atazanavir—ABCC1—Disease—AKT1—type 2 diabetes mellitus	3.58e-06	8.15e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—INS—type 2 diabetes mellitus	3.53e-06	8.05e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	3.37e-06	7.67e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.34e-06	7.61e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	3.34e-06	7.61e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	3.32e-06	7.57e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	3.3e-06	7.52e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	3.28e-06	7.47e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	3.24e-06	7.38e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	3.18e-06	7.25e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	3.1e-06	7.06e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	3.1e-06	7.06e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	3.1e-06	7.06e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	3.04e-06	6.93e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	3.03e-06	6.9e-05	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—AKT1—type 2 diabetes mellitus	2.99e-06	6.82e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	2.98e-06	6.78e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	2.97e-06	6.76e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	2.9e-06	6.6e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	2.9e-06	6.6e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	2.89e-06	6.58e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	2.85e-06	6.5e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	2.83e-06	6.46e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	2.74e-06	6.24e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	2.69e-06	6.12e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	2.65e-06	6.03e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	2.6e-06	5.93e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	2.56e-06	5.83e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	2.55e-06	5.81e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	2.52e-06	5.74e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	2.22e-06	5.06e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	2.18e-06	4.96e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	2e-06	4.55e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.91e-06	4.35e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.91e-06	4.35e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.75e-06	3.98e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	1.42e-06	3.25e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	1.33e-06	3.03e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	8.78e-07	2e-05	CbGpPWpGaD
